Zhou QY - Search Results

1

Pharmacogenetics of SLCO1B1 gene and the impact of *1b and *15 haplotypes on irinotecan disposition in Asian cancer patients.

Xiang X, Jada SR, Li HH, Fan L, Tham LS, Wong CI, Lee SC, Lim R, Zhou QY, Goh BC, Tan EH, Chowbay B. Xiang X, et al. Among authors: zhou qy. Pharmacogenet Genomics. 2006 Sep;16(9):683-91. doi: 10.1097/01.fpc.0000230420.05221.71. Pharmacogenet Genomics. 2006. PMID: 16906022 Clinical Trial.

2

Influence of UGT1A9 intronic I399C>T polymorphism on SN-38 glucuronidation in Asian cancer patients.

Sandanaraj E, Jada SR, Shu X, Lim R, Lee SC, Zhou Q, Zhou S, Goh BC, Chowbay B. Sandanaraj E, et al. Pharmacogenomics J. 2008 Jun;8(3):174-85. doi: 10.1038/sj.tpj.6500473. Epub 2007 Aug 14. Pharmacogenomics J. 2008. PMID: 17700594

3

Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients.

Chowbay B, Cumaraswamy S, Cheung YB, Zhou Q, Lee EJ. Chowbay B, et al. Pharmacogenetics. 2003 Feb;13(2):89-95. doi: 10.1097/00008571-200302000-00005. Pharmacogenetics. 2003. PMID: 12563178

4

Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer.

Zhou Q, Sparreboom A, Tan EH, Cheung YB, Lee A, Poon D, Lee EJ, Chowbay B. Zhou Q, et al. Br J Clin Pharmacol. 2005 Apr;59(4):415-24. doi: 10.1111/j.1365-2125.2004.02330.x. Br J Clin Pharmacol. 2005. PMID: 15801936 Free PMC article.

5

Role of UGT1A1*6, UGT1A1*28 and ABCG2 c.421C>A polymorphisms in irinotecan-induced neutropenia in Asian cancer patients.

Jada SR, Lim R, Wong CI, Shu X, Lee SC, Zhou Q, Goh BC, Chowbay B. Jada SR, et al. Cancer Sci. 2007 Sep;98(9):1461-7. doi: 10.1111/j.1349-7006.2007.00541.x. Epub 2007 Jul 11. Cancer Sci. 2007. PMID: 17627617 Free PMC article.

6

The modulation of irinotecan-induced diarrhoea and pharmacokinetics by three different classes of pharmacologic agents.

Chowbay B, Sharma A, Zhou QY, Cheung YB, Lee EJ. Chowbay B, et al. Among authors: zhou qy. Oncol Rep. 2003 May-Jun;10(3):745-51. Oncol Rep. 2003. PMID: 12684653

7

Effect of coenzyme Q10 on the disposition of doxorubicin in rats.

Zhou Q, Chowbay B. Zhou Q, et al. Eur J Drug Metab Pharmacokinet. 2002 Jul-Sep;27(3):185-92. doi: 10.1007/BF03190456. Eur J Drug Metab Pharmacokinet. 2002. PMID: 12365200

8

EGFR Intron 1 polymorphism in Asian Populations and its correlation with EGFR gene expression and amplification in breast tumor tissues.

Zhou Q, Cheung YB, Jada SR, Lim WT, Kuo WL, Gray JW, Lee AS, Chowbay B. Zhou Q, et al. Cancer Biol Ther. 2006 Nov;5(11):1445-9. doi: 10.4161/cbt.5.11.3457. Epub 2006 Nov 1. Cancer Biol Ther. 2006. PMID: 17102595

9

Determination of doxorubicin and its metabolites in rat serum and bile by LC: application to preclinical pharmacokinetic studies.

Zhou Q, Chowbay B. Zhou Q, et al. J Pharm Biomed Anal. 2002 Nov 7;30(4):1063-74. doi: 10.1016/s0731-7085(02)00442-9. J Pharm Biomed Anal. 2002. PMID: 12408897

10

Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models.

Zhou Q, Olivo M, Lye KY, Moore S, Sharma A, Chowbay B. Zhou Q, et al. Cancer Chemother Pharmacol. 2005 Dec;56(6):569-77. doi: 10.1007/s00280-005-1017-0. Epub 2005 Jul 7. Cancer Chemother Pharmacol. 2005. PMID: 16001166 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

251 results

Search Page

Filters